Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-22-002482
Filing Date
2022-06-27
Accepted
2022-06-27 09:29:44
Documents
8
Effectiveness Date
2022-06-27

Document Format Files

Seq Description Document Type Size
1 S-8 zk2228053.htm S-8 86800
2 EXHIBIT 4.3 exhibit_4-3.htm EX-4.3 155742
3 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 5721
4 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 4430
5 EXHIBIT 107 exhibit_107.htm EX-FILING FEES 23362
6 image00001.jpg GRAPHIC 87024
7 image00005.jpg GRAPHIC 21314
8 image00006.jpg GRAPHIC 3171
  Complete submission text file 0001178913-22-002482.txt   430829
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: S-8 | Act: 33 | File No.: 333-265845 | Film No.: 221041725
SIC: 2834 Pharmaceutical Preparations